Literature DB >> 21057872

Increasing batch-to-batch reproducibility of CHO cultures by robust open-loop control.

M Aehle1, A Kuprijanov, S Schaepe, R Simutis, A Lübbert.   

Abstract

In order to guarantee the quality of recombinant therapeutic proteins produced in mammalian cell systems, the straightforward approach in industry is to run the processes as reproducible as possible. It is first shown that considerable distortions in the currently operated processes appear when the initial cell density deviates from its nominal value. Small deviations in the initial cell mass may lead to severe deviations from the desired biomass trajectory. Next, it is shown how to design a fed-batch production process in such a way that it is robust with respect to variations in the viable cell density. A simple open loop strategy is proposed for that purpose. Here we show for the first time at animal cell cultures (CHO cells) that by means of an appropriate glutamine feed rate profile F(t), which keeps the specific growth rate of the cells on a predefined value below its maximal value while maintaining the viabilities on a high level, the diverging viable cell count profiles change over into a robust converging set of profiles. The CHO cells used to validate the procedure could be focused to any specific growth rates below μ(max).

Entities:  

Year:  2010        PMID: 21057872      PMCID: PMC3021148          DOI: 10.1007/s10616-010-9320-y

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  15 in total

1.  On-line monitoring of responses to nutrient feed additions by multi-frequency permittivity measurements in fed-batch cultivations of CHO cells.

Authors:  Sven Ansorge; Geoffrey Esteban; Georg Schmid
Journal:  Cytotechnology       Date:  2010-04-21       Impact factor: 2.058

2.  Selective expression of the soluble product fraction in Escherichia coli cultures employed in recombinant protein production processes.

Authors:  Stefan Gnoth; Rimvydas Simutis; Andreas Lübbert
Journal:  Appl Microbiol Biotechnol       Date:  2010-06-10       Impact factor: 4.813

Review 3.  Production of recombinant protein therapeutics in cultivated mammalian cells.

Authors:  Florian M Wurm
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

4.  Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies. 1994.

Authors:  Liangzhi Xie; Daniel I C Wang
Journal:  Biotechnol Bioeng       Date:  2006-10-05       Impact factor: 4.530

5.  Open-loop control of the biomass concentration within the growth phase of recombinant protein production processes.

Authors:  Marco Jenzsch; Stefan Gnoth; Matthias Beck; Martin Kleinschmidt; Rimvydas Simutis; Andreas Lübbert
Journal:  J Biotechnol       Date:  2006-06-15       Impact factor: 3.307

6.  Process Analytical Technology (PAT): batch-to-batch reproducibility of fermentation processes by robust process operational design and control.

Authors:  S Gnoth; M Jenzsch; R Simutis; A Lübbert
Journal:  J Biotechnol       Date:  2007-04-29       Impact factor: 3.307

7.  A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: effect of nutrient concentration, dilution rate, and pH.

Authors:  W M Miller; H W Blanch; C R Wilke
Journal:  Biotechnol Bioeng       Date:  1988-10-05       Impact factor: 4.530

8.  Development of a fed-batch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells.

Authors:  Shinobu Kuwae; Toyoo Ohda; Hiroshi Tamashima; Hideo Miki; Kaoru Kobayashi
Journal:  J Biosci Bioeng       Date:  2005-11       Impact factor: 2.894

9.  Catabolic control of hybridoma cells by glucose and glutamine limited fed batch cultures.

Authors:  J Ljunggren; L Häggström
Journal:  Biotechnol Bioeng       Date:  1994-09-20       Impact factor: 4.530

10.  Effect of feed rate on growth rate and antibody production in the fed-batch culture of murine hybridoma cells.

Authors:  J D Jang; J P Barford
Journal:  Cytotechnology       Date:  2000-03       Impact factor: 2.058

View more
  7 in total

1.  Increasing batch-to-batch reproducibility of CHO-cell cultures using a model predictive control approach.

Authors:  Mathias Aehle; Kaya Bork; Sebastian Schaepe; Artur Kuprijanov; Rüdiger Horstkorte; Rimvydas Simutis; Andreas Lübbert
Journal:  Cytotechnology       Date:  2012-03-27       Impact factor: 2.058

2.  Mechanistic Mathematical Models as a Basis for Digital Twins.

Authors:  André Moser; Christian Appl; Simone Brüning; Volker C Hass
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  A novel approach for using dielectric spectroscopy to predict viable cell volume (VCV) in early process development.

Authors:  Brandon J Downey; Lisa J Graham; Jeffrey F Breit; Nathaniel K Glutting
Journal:  Biotechnol Prog       Date:  2014 Mar-Apr

4.  A control strategy to investigate the relationship between specific productivity and high-mannose glycoforms in CHO cells.

Authors:  Dénes Zalai; Helga Hevér; Krisztina Lovász; Dóra Molnár; Patrick Wechselberger; Alexandra Hofer; László Párta; Ákos Putics; Christoph Herwig
Journal:  Appl Microbiol Biotechnol       Date:  2016-02-24       Impact factor: 4.813

5.  Dielectric Spectroscopy and Optical Density Measurement for the Online Monitoring and Control of Recombinant Protein Production in Stably Transformed Drosophila melanogaster S2 Cells.

Authors:  Jan Zitzmann; Tobias Weidner; Gerrit Eichner; Denise Salzig; Peter Czermak
Journal:  Sensors (Basel)       Date:  2018-03-18       Impact factor: 3.576

6.  Soft sensor for monitoring biomass subpopulations in mammalian cell culture processes.

Authors:  Paul Kroll; Ines V Stelzer; Christoph Herwig
Journal:  Biotechnol Lett       Date:  2017-08-07       Impact factor: 2.461

7.  Model-Based Methods in the Biopharmaceutical Process Lifecycle.

Authors:  Paul Kroll; Alexandra Hofer; Sophia Ulonska; Julian Kager; Christoph Herwig
Journal:  Pharm Res       Date:  2017-11-22       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.